About: Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1999 (uk) article scientifique publié en 1999 (fr) im Januar 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1999 (ast) artikull shkencor i botuar më 01 janar 1999 (sq) scientific article published on 01 January 1999 (en)
publication date	wds:Q74601674-81FB61EE-3973-4005-8920-530A736F0688
publication date	1999-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q74601674-14B0F047-3D00-44E3-B4BA-9DF1E9D113CA wds:Q74601674-356C2965-4C74-4081-864E-53FA48F9BB97 wds:Q74601674-83CCC6D6-23F6-4B10-B180-7DD942EDA39F
author name string	K M Fox D J Patel H J Purcell
rdfs:label	Cardioprotection by opening of the K (nl) Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas (en) Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas (sq)
skos:prefLabel	Cardioprotection by opening of the K (nl) Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas (en) Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas (sq)
name	Cardioprotection by opening of the K (nl) Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas (en) Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas (sq)
title	wds:Q74601674-264B7A52-F92C-411A-AAEF-2272677715BA
title	Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization (en)
page(s)	wds:Q74601674-5E91CCBB-FBCD-4919-8F39-F93CE2A456AA
page(s)	51-57
instance of	wds:Q74601674-9825EC5B-8905-43D3-A529-1B2D177880B5
instance of	scholarly article
PubMed ID	wds:Q74601674-3DAA6797-4EF3-418C-AAF0-37AD51269449
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10075141
PubMed ID	10075141
published in	wds:Q74601674-CB5414C5-C91E-4E38-9B35-1BD4517B5B5D
published in	European Heart Journal
issue	wds:Q74601674-A1D15703-5006-46EE-8ED9-F0A619F1936B
volume	wds:Q74601674-DFB307BD-DDB4-4828-8255-5EC337F8EDE5
issue	1
volume	20
DOI	wds:Q74601674-233DF1C1-E393-43B6-8CD6-E6D5EB55A0A7
DOI	http://dx.doi.org/10.1053/EUHJ.1998.1354
DOI	10.1053/EUHJ.1998.1354
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74601674
is cites work of	Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M Sulphonylurea action revisited: the post-cloning era. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial Ischemic preconditioning: protection against myocardial necrosis and apoptosis Use of nicorandil in cardiovascular disease and its optimization K(ATP) channel therapeutics at the bedside Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance Nitric oxide: an emerging role in cardioprotection? Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina pectoris. Cardiac KATP channels in health and disease Nicorandil protects cardiac mitochondria against permeability transition induced by ischemia-reperfusion. wd:Q26829973 Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Clinical relevance of ischemic preconditioning Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluati Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. Oral nicorandil recaptures the waned protection from preconditioning in vivo Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients Therapeutic potential of ischaemic preconditioning Vasodilator Therapy: Nitrates and Nicorandil The effects of potassium-ATP channel modulation on ventricular fibrillation and defibrillation in the pig heart Featured Article: Pharmacological postconditioning with delta opioid attenuates myocardial reperfusion injury in isolated porcine hearts Current Modalities and Mechanisms Underlying Cardioprotection by Ischemic Conditioning. Impact of nicorandil in angina: subgroup analyses Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney Pharmacological modulation, preclinical studies, and new clinical features of myocardial ischemic preconditioning. Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits Selective mitochondrial K(ATP) channel activation results in antiarrhythmic effect during experimental myocardial ischemia/reperfusion in anesthetized rabbits Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil Value and limitations of ambulatory ECG monitoring for assessment of myocardial ischemia The Nucleotide-Binding Sites of SUR1: A Mechanistic Model Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris Antiarrhythmic effect of ischemic preconditioning in recent unstable angina patients undergoing coronary artery bypass grafting Cardioprotective mechanisms of lifestyle modifications and pharmacotherapies on cardiac remodeling and dysfunction in hypertensive heart disease: an overview. Contemporary management of acute coronary syndrome Effects of acidosis and NO on nicorandil-activated K(ATP) channels in guinea-pig ventricular myocytes Harnessing the preconditioning phenomenon: does remote organ ischaemia provide the answer?
is cites work of	wds:Q30583012-535B724C-BFF4-43C5-BBB6-1F028AC9BCD2 wds:Q34523796-F40E02AE-0E68-4CF5-B8ED-E2F385342B00 wds:Q37031353-C81FF4F0-49A9-4D56-AAFE-C39CD9E5C934 wds:Q50514129-A28F0A56-AF77-456F-BF63-F35C2D517FA5 wds:Q73265872-AC4E1A28-7C55-45A8-9C68-BC3C83A2F6DC wds:Q26829973-38D2DE8F-C852-41B2-BA2A-42EFE239E863 wds:Q34124712-C262BC10-E6B1-4DB1-8762-C0E970BCDB9F wds:Q35159821-283B19E4-2C5E-41B4-9613-B2F1796D0886 wds:Q36161668-E10AD8BB-A9CD-4BE6-A95B-ACA549BFA7AB wds:Q34315285-68EC7A06-829F-4853-A036-8BD0609726EC wds:Q42579397-12C08D40-4516-4EA3-AFF6-F5F06D0D9460 wds:Q37895248-8742EF73-4F20-45EA-95B0-A5115FFBBB20 wds:Q43915750-8692141F-6496-412C-AD71-FB38BD24B3A9 wds:Q79287623-AB7BD4AC-55CF-4EBC-A17E-5C15330C3923

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software